Another possibility, especially in light of the association between raised HER2 and tumour marker (CA15.3 and CEA) expression observed in the present study (Table 3), is that these changes may simply be a reflection of tumour burden, in which a certain critical level of cells expressing HER2 is necessary for its detection in serum [18,19]. This evidence concerns the gene ERBB2 and neoplasm.